7 insiders reported 11 Form 4 transactions for ADIAL PHARMACEUTICALS, INC. (ADIL) over the past 18 months (most recent 2026-07-01). Recent activity: Coastlands Capital LP (Insider) Buy 25,000 shares, Davidson Matt (Chief Development Officer) Buy 61,647 shares, Davidson Matt (Chief Development Officer) Buy 3,427 shares, Davidson Matt (Chief Development Officer) Buy 232,417 shares, Davidson Matt (Chief Development Officer) Buy 1,822 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-01 | Coastlands Capital LP | Insider | Buy | 25,000 | $65,000 |
| 2026-06-16 | Davidson Matt | Chief Development Officer | Buy | 61,647 | $0 |
| 2026-06-16 | Davidson Matt | Chief Development Officer | Buy | 3,427 | $0 |
| 2026-06-16 | Davidson Matt | Chief Development Officer | Buy | 232,417 | $0 |
| 2026-06-16 | Davidson Matt | Chief Development Officer | Buy | 1,822 | $0 |
| 2026-06-16 | Davidson Matt | Chief Development Officer | Buy | 101 | $0 |
| 2026-04-09 | Claiborne Cary J | Chief Executive Officer | Buy | 37,985 | $0 |
| 2026-04-09 | Goodman Tony | Chief Operating Officer | Buy | 26,510 | $0 |
| 2026-04-09 | Schuyler Kevin | Director | Buy | 9,185 | $0 |
| 2026-04-09 | Gilliland Robertson H. | Director | Buy | 9,185 | $0 |
| 2026-04-09 | Shah Vinay | Chief Financial Officer | Buy | 17,325 | $0 |
Source: SEC Form 4 filings · as of 2026-07-01